Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.

The Clinical investigator - 1 Jul 1992

Feussner G, Ziegler R

Abstract excerpt

In a preceding paper, we described the molecular biological defects in a patient with a severe form of the familial lipoprotein disorder type III hyperlipoproteinemia (HLP) and an unusual apolipoprotein (apo) E1 phenotype and epsilon 1/"null" genotype. The index case was a 60-year-old white male of German ancestry who suffered from a myocardial infarction at age 50 years. He had distinctly elevated levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Apolipoproteins E
Share to Cholesterol, Dietary

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to Dietary Fats

Share to Genotype

Share to Hyperlipoproteinemia Type III

Source

Identifiers

PMID: 1392432
DOI: 10.1007/BF00184806

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.PMID 1392432Read ↗

Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.Semantic proximity Read ↗

Compound heterozygote for both rare apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) and E3(Cys112-->Arg, Arg251-->Gly) alleles in a multigeneration pedigree with hyperlipoproteinaemia.Semantic proximity Read ↗

Rare apolipoprotein E variant identified in a patient with type III hyperlipidaemia.Semantic proximity Read ↗

Molecular basis of type III hyperlipoproteinemia in Germany.Semantic proximity Read ↗

Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.Semantic proximity Read ↗

Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.Semantic proximity Read ↗

Genotyping of a patient homozygous for a rare apolipoprotein E1 [Gly127-->Asp; Arg158-->Cys] (Weisgraber allele).Semantic proximity Read ↗

APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required.Semantic proximity Read ↗

Rapid and reliable identification of human apolipoprotein E1 (Gly127-->Asp, Arg158-->Cys) variant.Semantic proximity Read ↗

Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.Semantic proximity Read ↗

New Frontiers in the Treatment of Homozygous Familial HypercholesterolemiaSemantic proximity Read ↗

Metreleptin as A Rescue Therapy in A Patient With A Novel Mutation for Familial Partial Lipodystrophy Type 3, Originally Presenting as Type 1 Diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.